Online CMC Regulatory Affairs Training | July 2026

Job Description

New Chapter Announcement – Online CMC Regulatory Affairs Training
Biologics | Biosimilars | Vaccines_Analytical-CMC Chapter
Fortunate-Veda RA Trainings is delighted to announce the launch of a new chapter in our Online CMC Regulatory Affairs Program, starting 27 July 2026, delivered through live interactive Zoom sessions.
🧪 Key Topics Covered
✅ Analytical Method Development (AMD)
✅ Analytical Method Qualification & Method Transfer
✅ Analytical Method Validation (AMV)
✅ Protein Characterization Strategies
✅ Reference Standards
✅ Biosimilarity Assessment & Analytical Comparability (QTPP, CPP & CQA Alignment)
✅ Bioassays & Immunoassays
✅ Extractables & Leachables (E&L) – ICH Q3E
✅ Nitrosamine Risk Assessment – Regulatory Expectations
✅ Elemental Impurity Risk Evaluation – ICH Q3D
✅ Statistical Tools Used in the Biopharmaceutical Industry
🎯 What You Will Gain
Gain comprehensive knowledge of Analytical CMC Regulatory Strategies for Biologics, Biosimilars, and Vaccines, aligned with global regulatory expectations from US FDA, EMA, WHO, and ICH. Enhance your technical expertise and strengthen your career in Regulatory Affairs.
📍 Program Details
🖥️ Mode: Live Interactive Zoom Sessions
🗓️ Start Date: 27 July 2026
⏰ Schedule: Monday to Friday | 08:30 PM – 10:00 PM (IST)
📞 Contact & Registration
🌐 www.fortunateveda.com
✉️ fortuneveda@gmail.com
📱 +91 86032 23334

🚀 Upgrade your Analytical CMC expertise and accelerate your Regulatory Affairs career with Fortunate-Veda RA Trainings!